Clinician's Roundtable

Host: Maria Berrocal Guest: Dimitra Skondra, MD Could metformin reduce risk of wet AMD development? Maria Berrocal, MD, speaks with Dimitra Skondra, MD, PhD, about a study published in Ophthalmology Retina finding that metformin exposure was associated with up to 30% lower odds of new-onset wet AMD. They discuss what the findings mean for patients with and without diabetes, where the protective ef...

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: John A. Scolaro, MD MA For anticoagulated patients with orthopedic or trauma fractures, delaying surgery to reduce bleeding risk may carry its own consequences. Join Dr. Charles Turck and Dr. John Scolaro as they explore how factors like surgical approaches, anticoagulation indications, comorbidities, transfusion-related risks, and physiologic reserv...

Guest: Darilyn Moyer, MD, MACP, FRCP, FIDSA, FAMWA, FEFIM With vaccination rates at historic lows and trust in public health institutions declining, primary care clinicians remain one of the most trusted sources of guidance for patients. Hear from Dr. Darilyn Moyer, Executive Vice President and Chief Executive Officer of the American College of Physicians, as she shares strategies for navigating d...

Host: Barton Lynn Blackorby, MD Guest: Kyle Davis Kovacs, MD Guest: Matthew Starr, MD How aggressively should you manage a vitreous hemorrhage after a PVD when you can't see the retina underneath it? Barton Blackorby, MD, moderates a discussion with Matt Starr, MD, and Kyle Kovacs, MD, about a study published in Ophthalmology by Hasbolat et al examining 366 patients with PVD-related vitreous hemor...

What happens when vitreous hemorrhage (VH) secondary to non-tractional PDR doesn't clear on its own? And does preoperative anti-VEGF actually change surgical outcomes? Maria Berrocal, MD, speaks with Sumit Sharma, MD, about a retrospective case series of 360 patients who underwent vitrectomy for non-clearing VH without tractional elements, examining whether preoperative anti-VEGF injection affects...

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Mallik Greene, PhD Guest: Jordan Karlitz, MD A study published in the Journal of the National Comprehensive Cancer Network examined follow-up colonoscopy rates after positive stool-based colorectal cancer screening tests, finding notably higher and faster completion rates with multi-target stool DNA testing compared to fecal immunochemical testing. The...

Host: Shelina Ramnarine, PhD Guest: David A. Johnson, MD, FACG, FACP Noninvasive colorectal cancer screening is only effective when abnormal results lead to timely, high-quality colonoscopy, but recent data shows significant gaps in follow-up. Join Dr. Shelina Ramnarine and Dr. David Johnson, Chief of Gastroenterology at Eastern Virginia Medical School at Old Dominion University, as they explore h...

Host: Brian P. McDonough, MD, FAAFP Guest: David A. Lieberman, MD Long-term effectiveness of colorectal cancer (CRC) screening depends on more than the performance of an individual test; it requires sustained adherence to recommended screening intervals and timely follow-up after abnormal results. But real-world data shows that many patients fall off track over time. Learn more about how we can im...

Host: Shelina Ramnarine, PhD Guest: Samuel Ubanyionwu, PharmD, EMBA Accurate IV medication delivery depends on more than proper pump programming alone. It requires a comprehensive understanding of smart pump drug libraries, dose error reduction software (DERS), infusion mechanics, and system-level safety procedures. To explore how these elements work together to support IV medication accuracy, pat...

Guest: Sayna Norouzi, MD Because patients with IgA nephropathy (IgAN) often have few symptoms early in the disease course, communicating the importance of treatment and its impacts on long-term outcomes can be challenging. Join Dr. Sayna Norouzi as she discusses practical communication techniques for explaining prognosis, setting expectations around therapy, and partnering with patients to support...

Guest: Anjay Rastogi, MD, PhD Managing IgA nephropathy (IgAN) is becoming increasingly complex. In this episode, Dr. Anjay Rastogi explains why an expert opinion—not simply a second opinion—can help clinicians confirm diagnoses, optimize treatment decisions, and connect appropriate patients with specialized care and emerging therapeutic opportunities. Dr. Rastogi is a Professor of Medicine and Cli...

Guest: Anjay Rastogi, MD, PhD Closer collaboration between nephrologists and pathologists is essential for optimizing the diagnosis and management of IgA nephropathy (IgAN). Hear from Dr. Anjay Rastogi as he highlights how pathology insights, clinical context, and ongoing communication can improve interpretation of kidney biopsy findings and support more informed treatment decisions. He's a Profes...

Host: Alexandria May, PharmD, BCPS Guest: David E. Griffith, MD Even as our understanding of nontuberculous mycobacterial (NTM) lung disease advances, major gaps remain, from defining meaningful treatment success to overcoming innate drug resistance. In this conversation with Dr. Alexandria May, Dr. David Griffith shares his perspective on how recent evidence is shaping treatment decisions for the...

Host: Brian P. McDonough, MD, FAAFP Guest: Doreen Addrizzo-Harris, MD The biggest challenge in diagnosing nontuberculous mycobacterial (NTM) lung disease isn't confirmation; it's thinking to look for NTM in the first place. In this conversation with Dr. Brian McDonough, Dr. Doreen Addrizzo-Harris examines the subtle clinical and radiographic features that can help identify NTM earlier, discusses b...

What do large registry data reveal about outcomes after intraocular foreign body removal, and how should those findings shape surgical planning and patient counseling? In this episode of New Retina Radio Journal Club with VBS, Jordan Deaner, MD, moderates a discussion with Vaidehi Dedania, MD, and Rehan Hussain, MD, on a 2025 IRIS Registry analysis of nearly 4,800 eyes. The group reviews the delay...

Host: Maria Berrocal Guest: Audina Berrocal, MD Does socioeconomic status influence outcomes in proliferative sickle retinopathy? In this episode of Clinical Minute: Retina, host Maria Berrocal, MD, speaks with Audina "Nina" Berrocal, MD, of Bascom Palmer Eye Institute, who published a retrospective review of more than 100 patients with proliferative sickle retinopathy. They explore whether the in...

Host: Maria Berrocal Guest: Audina Berrocal, MD Does socioeconomic status influence outcomes in proliferative sickle retinopathy? In this episode of Clinical Minute: Retina, host Maria Berrocal, MD, speaks with Audina "Nina" Berrocal, MD, of Bascom Palmer Eye Institute, who published a retrospective review of more than 100 patients with proliferative sickle retinopathy. They explore whether the in...

Guest: Jason Goldman, MD Scientific uncertainty is inevitable, but how we communicate it matters. Dr. Jason Goldman, President of the American College of Physicians and liaison to the CDC Advisory Committee on Immunization Practices, shares strategies for discussing the unknown with patients transparently and effectively.

Guest: Christopher Cann, MD Colorectal cancer is increasingly affecting younger adults, highlighting important gaps in current screening practices. Given this alarming trend, Dr. Christopher Cann discusses how rising incidence in patients under 50 challenges traditional screening thresholds and underscores the need for earlier risk assessment. He emphasizes the importance of family history, identi...

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Kenneth Olivier, MD, MPH Guest: Shelby MacRae, MD In patients with nontuberculous mycobacterial (NTM) lung disease, treatment decisions rarely follow a one-size-fits-all approach. In this expert-led discussion, Dr. Kenneth Olivier and Dr. Shelby MacRae join Dr. Charles Turck to explore how disease characteristics, patient priorities, and evolving cli...

Guest: Christopher Cann, MD Patient navigators play an increasingly vital role in improving colorectal cancer screening rates and closing gaps in preventive care. Beyond care coordination, they serve as key educators by identifying eligible patients, addressing barriers, and facilitating referrals for screening colonoscopy and other modalities. Learn more about how integrating patient navigation c...

Host: Gates B. Colbert, MD Guest: Sarina Schrager, MD Guest: Lashika Yogendran, MD Shared decision-making plays a critical role in improving colorectal cancer screening uptake by helping patients navigate emotional, logistical, and personal barriers to care. Joining Dr. Gates Colbert to discuss how individualized, patient-centered conversations can support screening decisions and improve completio...

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Aasma Shaukat, MD, MPH Despite strong recommendations for colorectal cancer screening, many eligible patients are still unscreened because of access and convenience issues. Emerging blood-based screening tests may help expand participation, but important questions remain about their ability to detect advanced precursor lesions and how they compare with...

Guest: Natalia Usoltseva MD, FACP, MHA Colorectal cancer (CRC) screening is most effective when it fits seamlessly into busy primary care workflows while still keeping patients engaged in the process. Join Dr. Natalia Usoltseva as she discusses practical ways to improve screening, from simplifying shared decision-making conversations and automating follow-up processes to ensuring patients receive...

Guest: Natalia Usoltseva MD, FACP, MHA Shared decision-making can be difficult to incorporate into already time-constrained primary care visits, especially when discussing colorectal cancer screening (CRC) options with patients. Join Dr. Natalia Usoltseva, a primary care provider at University of Washington Medicine, to hear how her practice implemented standardized decision-making tools to create...